Novavax, Inc.
NASDAQ:NVAX
| Market Cap (Intraday) | 1.31B |
| Current PE | 3.09 |
| Forward PE | 3.23 |
| 2yr Forward PE | N/A |
| 10-Day MA | $8.47 |
| 50-Day MA | $7.32 |
| 200-Day MA | $7.68 |
Novavax, Inc. Stock, NASDAQ:NVAX
700 Quince Orchard Road, Gaithersburg, Maryland 20878
United States of America
Phone: +1.240.268.2000
Number of Employees: 952
Description
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.